An online virtual-patient program to teach pharmacists and pharmacy students how to provide diabetes-specific medication therapy management

Am J Pharm Educ. 2012 Sep 10;76(7):131. doi: 10.5688/ajpe767131.

Abstract

Objective: To develop, implement, and assess the effectiveness of an online medication therapy management (MTM) program to train pharmacists and pharmacy students in providing MTM services for patients with diabetes and to increase their intent to perform these services.

Design: An online program was created using an Internet-based learning platform to simulate 4 MTM meetings between a pharmacist and a virtual patient diagnosed with diabetes.

Assessment: Eighty students and 42 pharmacists completed the program. After completing the program, scores on post-intervention assessments showed significant improvement in 2 areas: control over performing MTM, and knowledge of how to perform MTM. Students had a significantly less-positive attitude about MTM and a decline in their perception of the social expectation that MTM is part of the practice of pharmacy, while pharmacists' attitudes did not change significantly in these areas.

Conclusion: This online program using a virtual patient improved both participants' belief that they have control over performing MTM, and their knowledge of how to perform MTM for diabetic patients, which may increase the likelihood that pharmacists and pharmacy students will perform MTM in the future.

Keywords: diabetes; medication therapy management; pharmacist; pharmacy student; simulation; virtual patient.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Attitude of Health Personnel
  • Communication
  • Diabetes Mellitus / drug therapy*
  • Education, Pharmacy / methods*
  • Female
  • Health Knowledge, Attitudes, Practice
  • Humans
  • Hypoglycemic Agents / therapeutic use*
  • Internet*
  • Male
  • Medication Therapy Management / education*
  • Middle Aged
  • Pharmacists
  • Professional Role
  • Students, Pharmacy
  • User-Computer Interface

Substances

  • Hypoglycemic Agents